Alliance For Cancer Gene Therapy Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2020 | 2,302,328 | 1,908,266 | 394,062 | 28.6 | 8% |
| 2021 | 1,716,695 | 2,586,563 | −869,868 | 23.4 | 8% |
| 2022 | 3,295,905 | 1,804,221 | 1,491,684 | 38.4 | 14% |
| 2023 | 3,231,770 | 2,498,579 | 733,191 | 30.0 | 16% |
In its most recent public year (2023), this organization brought in $733,191 more than it spent. Its reserves stood at about 30 months of spending, up from 28.6 in 2020. Staff pay was 16% of spending. $2,234,834 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works